- Home
- EBAY vs ARGX Comparison
EBAY vs ARGX Comparison
Compare EBAY & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBAY
- ARGX
- Stock Information
- Founded
- EBAY 1995
- ARGX 2008
- Country
- EBAY United States
- ARGX Netherlands
- Employees
- EBAY N/A
- ARGX N/A
- Industry
- EBAY Business Services
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EBAY Consumer Discretionary
- ARGX Health Care
- Exchange
- EBAY Nasdaq
- ARGX Nasdaq
- Market Cap
- EBAY 31.1B
- ARGX 37.3B
- IPO Year
- EBAY 1998
- ARGX 2017
- Fundamental
- Price
- EBAY $65.01
- ARGX $623.82
- Analyst Decision
- EBAY Buy
- ARGX Strong Buy
- Analyst Count
- EBAY 26
- ARGX 20
- Target Price
- EBAY $62.32
- ARGX $634.50
- AVG Volume (30 Days)
- EBAY 4.6M
- ARGX 290.3K
- Earning Date
- EBAY 10-30-2024
- ARGX 10-31-2024
- Dividend Yield
- EBAY 1.66%
- ARGX N/A
- EPS Growth
- EBAY N/A
- ARGX N/A
- EPS
- EBAY 3.97
- ARGX N/A
- Revenue
- EBAY $10,266,000,000.00
- ARGX $1,908,659,000.00
- Revenue This Year
- EBAY $3.72
- ARGX $61.99
- Revenue Next Year
- EBAY $3.23
- ARGX $42.48
- P/E Ratio
- EBAY $16.32
- ARGX N/A
- Revenue Growth
- EBAY 2.05
- ARGX 85.56
- 52 Week Low
- EBAY $40.16
- ARGX $349.86
- 52 Week High
- EBAY $67.80
- ARGX $644.97
- Technical
- Relative Strength Index (RSI)
- EBAY 59.64
- ARGX 58.04
- Support Level
- EBAY $62.60
- ARGX $613.95
- Resistance Level
- EBAY $66.52
- ARGX $644.97
- Average True Range (ATR)
- EBAY 1.65
- ARGX 14.33
- MACD
- EBAY 0.08
- ARGX -0.42
- Stochastic Oscillator
- EBAY 71.83
- ARGX 50.28
About EBAY eBay Inc.
EBay operates one of the largest e-commerce marketplaces in the world, with $73 billion in 2023 gross merchandise volume rendering the firm a top 10 global e-commerce company. It generates revenue from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2023. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.